Sannova provides method development and TK sample analysis, leveraging state-of-the-art facilities and expert scientific teams to evaluate the safety profiles of pharmaceutical compounds. Our toxicology studies encompass both in vitro and in vivo assessments, across a range of species. These studies analyze the safety and efficacy of potential therapeutics, providing insights into drug exposure, potential toxicity, and expected API behavior in biological matrices. Through precise bioanalytical support and advanced analytical techniques, we generate detailed toxicokinetic profiles that help clients understand drug exposure levels and potential safety concerns.

Working closely with sponsors throughout the drug development process, Sannova’s team of experts develops highly selective and sensitive assays that align with regulatory requirements and specific program needs. Our experienced team will work through an iterative process as needed to develop even the most challenging assays. This comprehensive assessment helps identify potential safety risks early in development, supports IND submissions, and provides valuable insights for determining safe dosing ranges in clinical trials. Our scientists maintain rigorous documentation practices and deliver high-quality data packages that meet stringent regulatory standards.